Topic: Cirrhosis and complications
Best of ILC 2018 Cirrhosis and complications deck
Topic: Immune mediated and cholestatic diseases
Best of ILC 2018 Cholestatic and autoimmune
Topic: Cirrhosis and complications
Clinical Practice Guidelines Decompensated cirrhosis
Topic: General hepatology
Clinical Practice Guidelines Vascular diseases of the liver
Topic: General hepatology
Clinical Practice Guidelines Liver transplantation
Topic: Metabolism, alcohol and toxicity
Clinical Practice Guidelines Non-Alcoholic fatty liver disease
Topic: Immune mediated and cholestatic diseases
Clinical Practice Guidelines Endoscopy in PSC
Topic: Liver tumours
Clinical Practice Guidelines Benign liver tumours
Topic: General hepatology
Clinical Practice Guidelines Acute liver failure
Topic: Immune mediated and cholestatic diseases
Clinical Practice Guidelines Autoimmune hepatitis
You may be interested in
- On behalf of the European Health Alliance on Alcohol (EHHA), the European Association for the Study of the Liver (EASL) welcomes the European Parliament’s decision to safeguard consumers by endorsing clear and accurate “reduced-alcohol” labelling.
- DECISION – Project publishes fundamental study on immune mechanisms predicting outcomes in patients with ADC
- EASL Mobility / Research Fellowship Programme










